The presence of T2D in MASLD was associated with a 2.9-fold increase in the odds of AOPP levels, a 3.7-fold increase in the odds of TLR9 mRNA expression, and a 2.1-fold increase in the odds of CD36 mRNA expression being in the high-risk tertile. The gene discussed is CD36; the disease is type 2 diabetes mellitus.